Register to receive a free U.S. Market Report Suite for Infusion Therapy Device –MedSuite report synopsis and brochure
Imprivata®, the healthcare IT security company, announced a new collaboration with ICU Medical Inc., a leader in the development, manufacture, and sale of innovative medical products used in infusion therapy and critical care applications, to enhance the security of medical devices. Working together, Imprivata and ICU Medical will develop solutions to identify users and improve physical security and cybersecurity for network-connected infusion pumps.
The Imprivata and ICU Medical collaboration focuses on developing solutions designed to address security vulnerabilities for network-connected medical devices and the applications with which they exchange information. By enabling fast, secure authentication when accessing patient information, and performing transactional workflows on medical devices and the applications through which they operate, this integrated technology will enhance security and auditing capabilities for medical devices, while at the same time focus on improving clinician efficiency and patient safety.
“Cybersecurity and user authentication continue to be at the forefront of conversations with our healthcare customers. Innovating new solutions with Imprivata reinforces our commitment to higher levels of security and greater visibility for our integrated infusion systems and hospital partners,” said Matthew Hutchings, ICU Medical’s senior director of marketing and innovation for IV Systems.
“Infusion pumps are rapidly increasing in their level of integration on hospital networks as EHR integration is becoming the standard of care. In today’s Internet of Medical Things environment, security threats can come from many sources,” said Wes Wright, Chief Technology Officer at Imprivata. “We’re excited to work closely with ICU Medical to innovate new ways to lock down these connected devices and authenticate users with security profiles for the benefit of our customers and hospital partners.”
About ICU Medical
ICU Medical, Inc. is one of the world’s leading pure-play infusion therapy companies with global operations and a wide ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needle-free connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, the company manufactures automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. ICU Medical is headquartered in San Clemente, California. On February 3, 2017, ICU Medical completed the acquisition of the Hospira Infusion Systems business from Pfizer.
For Further Information
More on the infusion therapy device market in the U.S. can be found in a series of reports published by iData entitled the U.S. Market Report Suite for Infusion Therapy Devices. The full report suite on the U.S. market for infusion therapy includes infusion pumps, intravenous (IV) sets, needleless connectors (NLCs) and stopcocks.
The iData series on the market for infusion therapy devices covers the U.S. and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxembourg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about infusion therapy device market data, register online or email us at [email protected] for a U.S. Market Report Suite for Infusion Therapy Devices brochure and synopsis.